Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

MGIC Investment Corp. (MTG) Tops Wall Streets’ Earnings Expectations, Shares Dip

Page 1 of 2

MGIC Investment Corp. (NYSE:MTG) has beaten the market’s earnings expectations with its second quarter financial results, posting earnings per share of $0.28. However, its quarterly revenues of $243.1 million were below the markets’ estimates. The market had an earnings estimate of $0.23 for the second quarter of fiscal 2015 over revenues of $247.16 million. It is important to note that the investment company did miss the revenue expectations in the second quarter fiscal 2014 as well, with revenues of $231.2 million against estimates of $237.1 million. It was an excellent quarter for MGIC Investment Corp. (NYSE:MTG) in terms of new insurance as the company wrote insurance worth $11.8 billion for the quarter against the prior year figure of $8.3 billion. The insurance firm reported growth of 5.9% in its net insurance in force at $168.8 billion at the end of the second quarter compared to the end of the second quarter one year prior.


Patrick Sinks, CEO of MGIC Investment Corp. (NYSE:MTG), said, “I am pleased to report that in the second quarter of 2015 the company continued to grow our insurance in force by adding another $11.8 billion of high quality new insurance.” He further added, ” The combination of profitable new business, the continued runoff of the older books, and a strengthened housing market, positions us well to provide credit enhancement solutions to our customers now and in the future.”

It has been a good year so far for MGIC Investment Corp. (NYSE:MTG)’s shareholders, as its shares have grown by 21.57% year-to-date, though shares have fallen by 1.66% in morning trading today following the results. The investment firm found a place in Barclays Americas Top Picks list under the financial sector earlier this year. Smart money however was slightly bearish towards the stock of the company during the first quarter, as 54 hedge fund investors held positions worth $1.78 billion against prior quarter investments of $1.77 billion made by 57 hedge fund managers. The marginal growth in aggregate holdings while the stock gained 14.64% during the first quarter indicates fund managers also collectively sold off shares.

We don’t just track the latest moves of funds. We are, in fact, more interested in their 13F filings, which we use to determine the top 15 small-cap stocks held by the funds we track. We gather and share this information based on 16 years of research, with backtests for the period between 1999 and 2012 and forward testing for the last 2.5 years. The results of our analysis show that these 15 most popular small-cap picks have a great potential to outperform the market, beating the S&P 500 Total Return Index by nearly one percentage point per month in backtests. Moreover, since the beginning of forward testing in August 2012, the strategy worked brilliantly, outperforming the market every year and returning 139%, which is more than 80 percentage points higher than the returns of the S&P 500 ETF (SPY) (see more details).

Despite bearish hedge fund sentiment, insiders at MGIC Investment Corp. (NYSE:MTG) were bullish on the stock and rightly so. Daniel Arrigoni, Director at MGIC Investment, purchased 10,000 shares of the company on March 10 at a price of $9.19 per share. The shares have appreciated by 23% since then.

 With all of this in mind, we’re going to take a look at the key smart money action surrounding MGIC Investment Corp. (NYSE:MTG).

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!